Literature DB >> 23439599

The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina.

Alfred K Yu1, Kevin D Merrill, Steven N Truong, Krisztina M Forward, Lawrence S Morse, David G Telander.   

Abstract

PURPOSE: Therapeutic retinal laser photocoagulation can damage the neurosensory retina and cause iatrogenic visual impairment. Subthreshold micropulse photocoagulation may decrease this risk by selective tissue treatment. The aim of this study was to compare subthreshold 810-nm diode micropulse laser and subthreshold 532-nm micropulse laser on the retina by histologic examination and differential protein expression.
METHODS: Fourteen Dutch-belted rabbits received subthreshold 810-nm diode micropulse laser photocoagulation in their right eye and subthreshold 532-nm micropulse laser photocoagulation in their left eye. Histology and immunohistochemical detection of stromal cell-derived factor-1 (SDF-1), β-actin, vascular endothelial growth factor (VEGF), glial fibrillary acidic protein (GFAP), and insulin-like growth factor 1 (IGF-1) were analyzed 12 hours, 3 days, 14 days, and 28 days post-laser photocoagulation.
RESULTS: Histologically, all time points produced a similar degree of retinal disruption in both wavelengths. Immunohistochemically, SDF-1 expression was greatest at the 12-hour time point and decreased thereafter. SDF-1, VEGF, and β-actin up-regulation was detected at early time points in both the 810- and 532-nm micropulse laser-treated animals.
CONCLUSIONS: Subthreshold micropulse retinal laser photocoagulation caused equivalent histologic changes from both 532- and 810-nm diode lasers. Differential protein expression was not evident between the different laser conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439599     DOI: 10.1167/iovs.12-11382

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Calibration of histological retina specimens after fixation in Margo's solution and paraffin embedding to in-vivo dimensions, using photography and optical coherence tomography.

Authors:  Stefan Koinzer; Sandra Bajorat; Carola Hesse; Amke Caliebe; Marco Bever; Ralf Brinkmann; Christoph Roecken; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-14       Impact factor: 3.117

2.  Morphologic changes in the retina after selective retina therapy.

Authors:  Ji Ho Yang; Seung-Young Yu; Tae Gi Kim; Eung Suk Kim; Hyung Woo Kwak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-18       Impact factor: 3.117

Review 3.  Pachychoroid disease spectrum: review article.

Authors:  Thiago José Muniz Machado Mazzeo; Henrique Monteiro Leber; Allan Gomes da Silva; Raimunda Cristina Mendonça Freire; Gabriel Castilho Sandoval Barbosa; Guilherme Garcia Criado; Gabriel Almeida Veiga Jacob; Cleide Guimarães Machado; André Marcelo Vieira Gomes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-14       Impact factor: 3.117

4.  Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema.

Authors:  Tomoaki Tatsumi; Yoko Takatsuna; Toshiyuki Oshitari; Tomomi Kaiho; Yohei Kawasaki; Yuki Shiko; Takeshi Sugawara; Takayuki Baba; Shuichi Yamamoto
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

5.  Application of subthreshold laser therapy in retinal diseases: a review.

Authors:  Spencer M Moore; Daniel L Chao
Journal:  Expert Rev Ophthalmol       Date:  2018-12-11

6.  Micropulse laser in patients with refractory and treatment-naïve center-involved diabetic macular edema: short terms visual and anatomic outcomes.

Authors:  Diego Alejandro Valera-Cornejo; Marlon García-Roa; Jaime Quiroz-Mendoza; Alejandro Arias-Gómez; Paulina Ramírez-Neria; Yolanda Villalpando-Gómez; Veronica Romero-Morales; Renata García-Franco
Journal:  Ther Adv Ophthalmol       Date:  2021-01-19

7.  Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.

Authors:  Myrte B Breukink; Susan M Downes; Giuseppe Querques; Elon H C van Dijk; Anneke I den Hollander; Rocio Blanco-Garavito; Jan E E Keunen; Eric H Souied; Robert E MacLaren; Carel B Hoyng; Sascha Fauser; Camiel J F Boon
Journal:  Trials       Date:  2015-09-21       Impact factor: 2.279

8.  Sublethal Photothermal Stimulation with a Micropulse Laser Induces Heat Shock Protein Expression in ARPE-19 Cells.

Authors:  Keiji Inagaki; Takuya Shuo; Kanae Katakura; Nobuyuki Ebihara; Akira Murakami; Kishiko Ohkoshi
Journal:  J Ophthalmol       Date:  2015-11-30       Impact factor: 1.909

9.  Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.

Authors:  Emin Özmert; Sibel Demirel; Özge Yanık; Figen Batıoğlu
Journal:  J Ophthalmol       Date:  2016-08-15       Impact factor: 1.909

10.  Photobiomodulation for non-exudative age-related macular degeneration.

Authors:  Christin Henein; David Hw Steel
Journal:  Cochrane Database Syst Rev       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.